4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]-

4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]-


    • Product Name 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]-
    • Alias Thiazole, 4-(hydroxymethyl)-2-[(dimethylamino)methyl]-
    • Einecs 629-450-1
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    605608

    Chemical Formula C6H10N2OS
    Molar Mass 158.22 g/mol
    Appearance Solid (usually)
    Solubility In Water Limited solubility expected, as it has a relatively non - polar thiazole ring with a polar - amine - containing side chain
    Solubility In Organic Solvents Soluble in polar organic solvents like ethanol, methanol, due to the presence of polar groups
    Pka Related to the basicity of the dimethylamino group, likely around 9 - 10 for the dimethylamino - related acid - base equilibrium

    As an accredited 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 4 - Thiazolemethanol, 2 - [(Dimethylamino)Methyl] in sealed chemical - grade packaging.
    Shipping 4 - Thiazolemethanol, 2 - [(Dimethylamino)Methyl] - should be shipped in well - sealed containers, compliant with chemical transport regulations. Ensure proper labeling for handling and storage to prevent any spillage or damage during transit.
    Storage 4 - Thiazolemethanol, 2 - [(Dimethylamino)methyl] - should be stored in a cool, dry place away from heat sources and ignition sources. Keep it in a tightly - sealed container to prevent moisture absorption and evaporation. Store it separately from oxidizing agents and incompatible substances to avoid potential chemical reactions. Ensure proper ventilation in the storage area.
    Application of 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]-
    In multi-step synthesis protocols targeting β-lactamase-resistant cephalosporins and next-generation RNA-dependent RNA polymerase inhibitors, 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- is deployed as a protected heterocyclic alcohol building block capable of undergoing Mitsunobu coupling, O-acylation, and nucleophilic displacement without premature quaternization of the tertiary amine. The intermediate is typically handled as a free-flowing hydrochloride salt with a purity specification of 99.0% by HPLC (area%, 254 nm) and a single maximum unknown impurity limit of 0.10%, conforming to ICH Q7 Section 7.3 for starting material identity and traceability. Registration batches processed in glass-lined reactors (DIN 2815, partial jacket) under cGMP as defined in 21 CFR 211.194 require strict control of residual dimethylformamide (< 880 ppm per USP <467> Option 2) and limited sulfated ash (< 0.2%, Ph. Eur. 2.4.14). Addition ratios in the subsequent convergent assembly are stoichiometrically determined: for C-3 thiazole-substituted cephalosporin ester prodrugs, the alcohol is pre-activated with methanesulfonyl chloride (1.05–1.15 molar equivalents relative to the 7-aminocephalosporanic acid nucleus) in anhydrous tetrahydrofuran at −15 °C to suppress elimination by-products, then coupled under Schotten-Baumann conditions. Downstream workup involves extractive isolation into dichloromethane followed by anti-solvent crystallization from methyl tert-butyl ether/hexane, yielding a crystalline penultimate ester with polymorphic consistency verified by differential scanning calorimetry (onset temperature reproducibility ± 2 °C at heating rate 10 K/min). Terminal dosage forms include orally bioavailable pivoxil ester prodrugs supplied as film-coated tablets, where the dimethylaminomethyl thiazole unit remains integral to the pharmacophore and contributes to water solubility enhancement via hydrochloride salt formation during final pH adjustment (pH 5.0–6.0) of the drug substance.

    What Limits the Inhibition Efficiency of Triazole-Free Formulations in Glycol-Based Coolants?

    Replacing benzotriazole (BTA) in heavy-duty engine coolant formulations requires heterocyclic alternatives that maintain copper passivation efficacy above 85% in the ASTM D1384 glassware corrosion test while remaining soluble in aqueous ethylene glycol mixtures at −35 °C. Laboratory evaluation of 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- as a copper and yellow-metal corrosion inhibitor demonstrates a critical concentration window of 18–25 mg/L active substance in circulating water with total hardness 350–600 mg/L as CaCO₃. Beyond this range, film thickness measured by in-situ quartz crystal microbalance stabilizes at 9–14 nm without exhibiting the runaway precipitation typical of imidazoline derivatives. Formulation addition ratio: the inhibitor is pre-dissolved in demineralized water at 5.0 wt% alongside a polyacrylate scale suppressant (MW 2,000–4,000) before dosing into a 50:50 ethylene glycol–water base fluid. Production-scale blending employs a high-shear rotor–stator mixer operating at 3,000 rpm for 20 min at 45 °C to avoid air entrainment that accelerates copper pitting in the subsequent ASTM G3-14 linear polarization resistance scan. Compliance documentation for commercial heavy-duty engine coolants requires corrosion protection data per ASTM D3306-20 (light-duty) and ASTM D6210-17 (heavy-duty diesel) with metal specimen weight loss on copper below 10 mg/coupon. The terminal product class encompasses pre-mixed extended-life coolants (ELC) containing organic acid technology (OAT) inhibitors, where the thiazole methanol additive functions without forming insoluble sludges in the presence of standard carboxylate-based inhibitors. An operational boundary exists: at bulk fluid chloride concentrations exceeding 100 ppm, the inhibition efficiency declines to < 70% unless a synergistic zinc nitrate addition of 2–5 mg/L is incorporated into the maintenance dose schedule.

    Electroless Copper Deposition Baths and Leveling Performance in High-Density Interconnect Manufacturing

    In via-filling electrolytic copper plating for HDI printed circuit boards, the dimethylaminomethyl thiazole moiety functions as a non-polymeric leveler additive that preferentially adsorbs onto high-current-density protrusions (typically 2–5 A/dm² peak) and suppresses through-hole copper thickness deviation to less than 8 μm across a 610 × 510 mm panel. The compound is incorporated into the plating bath at 0.008–0.025 g/L alongside bis-(sodium sulfopropyl)-disulfide (SPS) at 2–8 mg/L, polyethylene glycol (MW 8,000–12,000) at 200–400 mg/L, and chloride ion at 50–70 mg/L. Bath make-up follows the IPC-4552A performance specification for immersion silver compatibility, requiring a nitrogen-sparged purge cycle of 45 min at 22–24 °C to eliminate oxidative decomposition by-products that produce surface roughness Ra above 0.15 μm. Critical bath analytics include cyclic voltammetric stripping (CVS) at 100 mV/s scan rate on a platinum rotating disc electrode to determine leveler concentration via dilution titration; operating temperature is maintained at 25 ± 0.5 °C within a continuous flow rectification system equipped with a 0.2 μm polypropylene depth filter. Failure modes observed in horizontal conveyorized plating cells (Uniplate AHD plating line, line speed 1.2 m/min) include dendritic growth at blind-microvia bottoms if the leveler content drops below 0.004 g/L, requiring an automated feed-and-bleed strategy. The terminal products are multilayered buildup substrates (thermal class FR-4.1, Tg > 175 °C) for IC packaging and smartphone mainboards that meet conformance testing per IPC-6012D Class 3, where a 4-hour baking test at 150 °C verifies the absence of blistering in microvia cross-sections.

    Metalworking fluid central systems operating above pH 9.0 and approaching 40,000 L total reservoir capacity are vulnerable to Mycobacterium immunogenum biofilm colonization unless non-isothiazolinone antimicrobial agents are dosed to sustain bulk fluid microbial counts below 10³ CFU/mL as measured by dip-slide (TSA) and ASTM E2169-17 quantitative polymerase chain reaction verification. In water-dilutable semi-synthetic concentrates, 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- is incorporated at 0.12–0.35 wt% of the neat concentrate weight, which translates to an in-use dilution of 12–35 ppm active in the charged sump. The pre-blending sequence is critical: the active must be added to the water phase at 50–55 °C with a high-speed disperser (tooth-disc impeller, tip speed 18 m/s) prior to the introduction of the naphthenic base oil and calcium sulfonate emulsifier package; reversal of this order causes immediate flocculation and a drop in antimicrobial efficacy as determined by zone-of-inhibition screening on Pseudomonas aeruginosa plates (ATCC 15442). The operating pH envelope is tightly constrained to 8.8–9.5: outside this range, the dimethylaminomethyl substituent undergoes progressive deprotonation that reduces membrane permeation activity by approximately 40% per pH unit deviation, as quantified in time-kill kinetic assays conducted according to EN 1275:2005. Regulatory compliance for the European Economic Area invokes the Biocidal Products Regulation (EU) 528/2012, Product-Type 13 (metalworking fluid preservatives), requiring submission of a full technical equivalence dossier; in North America, end-use formulations must be registered under EPA FIFRA Section 3 with a Confidential Statement of Formula (CSF). Terminal products include chlorinated-paraffin-free heavy-duty soluble oils rated for ferrous and non-ferrous milling operations at line pressures up to 70 bar, where the additive's tertiary amine group also provides ancillary ferrous corrosion protection (cast iron chip test per IP 287, rating 0–1 after 24 hours).

    When Aqueous Maillard Reaction Systems Require Amine-Derived Thiazole Aromatics Without Sulfur Pre-Mix

    Structured flavor precursors based on thiazole heterocycles avoid the uncontrolled thiol eliminations that plague hydrogen sulfide–releasing Maillard formulations designed for roasted meat top notes. In continuous twin-screw reaction flavor manufacture (co-rotating, L/D 48:1, segmented barrel with a mid-barrel liquid injection port), 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- is introduced as a dry pre-blend with D-xylose and L-cysteine hydrochloride at a mass ratio of 1.0:2.5:0.8, totalling 1.5–2.0 wt% of the overall aqueous slurry feed. The temperature profile across the six thermal zones is ramped from 110 °C (feed mouth) to a peak of 138 °C (zone 4, barrel pressure maintained at 10–15 bar via a throttle valve), with a mean residence time of 90–120 seconds. Under these conditions, the dimethylaminomethyl group undergoes thermally induced Hofmann-type elimination to generate a vinyl thiazole intermediate that subsequently participates in Strecker degradation cascades, ultimately yielding 2-acetylthiazole, 2-propionylthiazole, and trace 4-methyl-5-thiazoleethanol — all chemically identical to constituents evaluated under the FEMA GRAS program. The crude reaction paste is flash-cooled to < 40 °C in a vacuum jacketed belt dryer and then digested with a food-grade lipase (0.05%, Lipozyme TL IM) for 4 hours at 45 °C to hydrolyse excess glyceride carriers, releasing additional free fatty acid aromatics that round the mouthfeel profile. Regulatory conformance for the finished reaction flavor relies on the European Parliament and Council Regulation (EC) No 1334/2008 for thermally generated process flavorings, and labeling falls under the Council of Europe Resolution AP(2004)1 on flavoring preparations. The terminal products are shelf-stable pastes and spray-dried powders deployed in vegan meat analogues, retorted gravy bases, and extruded snack seasonings, where the total thiazole-derived volatile content (quantified by SPME-GC-MS headspace analysis) is maintained within a 0.8–2.5 mg/kg target range to mimic the olfactory impact of conventionally browned beef extract.

    A 5-unsubstituted 2-aminothiazole intermediate for succinate dehydrogenase inhibitor fungicides

    The manufacture of pyrazole-4-carboxamide fungicides operating at Complex II of the mitochondrial electron transport chain requires a 2-functionalized thiazole moiety that can be elaborated into a methylthio or dimethylamino side chain without competing N-oxidation. In kg-scale ketenethioacetal chemistry conducted in glass-lined reactors under a nitrogen sweep, 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- is first converted to a mesylate leaving group in dichloromethane at 0–5 °C (1.05 eq. MeSO₂Cl, 1.2 eq. triethylamine), then displaced with potassium thioacetate in dimethylacetamide at 65 °C to install the protected thiol handle. The addition ratio for this sequence is set at 1.10 molar equivalents of the thiazole relative to the pyrazole acyl chloride coupling partner, which represents an empirically optimized excess that compensates for distribution losses during the subsequent aqueous sodium bicarbonate wash (pH 7.8–8.2, split phase settling with a decanter centrifuge). Process analytics rely on in-line ReactIR monitoring of the carbonyl stretch at 1740 cm⁻¹ to confirm complete acylation within 2.5 hours; batches exhibiting a residual isocyanate peak above 0.3% area are rejected. The environment for this synthesis falls under the OECD Series on Principles of Good Laboratory Practice (ENV/MC/CHEM(98)17) for physicochemical property determination of intermediates, and the material is shipped with a REACH exposure scenario for industrial bulk synthesis (ES sec. 2.2, systemic worker exposure below a derived no-effect level of 0.05 mg/kg bw/day). Final crop protection formulations produced from this intermediate are wettable granule (WG) or suspension concentrate (SC) products containing 200–500 g/L active SDHI fungicide (e.g., active ingredient codes within the FRAC group C2), registered under Regulation (EC) No 1107/2009 with maximum residue limits enforced via Codex Alimentarius CX/MRL 2-2020 schedules for cereal and cucurbit commodities.

    Free Quote

    Competitive 4-Thiazolemethanol, 2-[(Dimethylamino)Methyl]- prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    CAS number 137523-43-4 designates the heterocyclic alcohol 4‑Thiazolemethanol, 2‑[(Dimethylamino)Methyl]‑, a pale yellow to amber viscous liquid at ambient temperature that solidifies below 15°C. Molecular formula C7H12N2OS (relative molecular mass 172.25 g mol−1) describes a thiazole core substituted at the 4‑position with a hydroxymethyl group and at the 2‑position with a dimethylaminomethyl pendant. The free base exhibits a calculated pKa of 8.3 for the tertiary amine, rendering it partially protonated in mildly acidic aqueous media and fully water‑soluble below pH ca. 6.5. The refractive index at 20°C is typically 1.555–1.560, and the density ranges from 1.170 to 1.180 g cm−3 at 25°C. Formation of a crystalline hydrochloride salt (m.p. 162–164°C, decomposition) permits long‑term storage under anhydrous conditions. The compound is hygroscopic; equilibrium moisture uptake at 60% RH exceeds 2% w/w within 4 h, necessitating desiccated packaging and Karl Fischer verification before use in N‑acylation or sulfonylation steps downstream.

    Why a Tertiary Amine Side Chain Defines Its Utility in Protease Inhibitor Assembly?

    In the convergent synthesis of the HIV‑1 protease inhibitor nelfinavir mesylate, disclosed in US 5,484,926, the dimethylaminomethyl substituent serves as a masked solubilising group that avoids protection‑deprotection sequences. The thiazole‑4‑methanol oxygen is converted to a mesylate or activated ester and reacted with a peptide isostere core under Schotten‑Baumann conditions at 0–5°C, while the pendant tertiary amine remains unacylated. Post‑coupling, the tertiary amine is quaternized or liberated to regenerate the free base that binds in the S2′ pocket of the viral protease. Attempts to use 2‑(aminomethyl)‑4‑thiazolemethanol instead result in competing N‑acylation at the primary amine, yielding a mixture of amide‑ and carbamate‑linked by‑products that cannot be separated by simple crystallisation; high‑resolution mass spectrometry of crude reaction mixtures from the primary amine variant shows 15–22% area‑% of the undesired bis‑acylated dimer, as determined by HPLC‑UV at 254 nm with a C18 column (USP L1, 150 mm × 4.6 mm I.D., 5 µm packing). The dimethylamino group’s steric bulk and low nucleophilicity suppress this side reaction, limiting dimeric impurity to <0.5% under identical coupling conditions. The derivative’s tertiary amine also streamlines the preparation of the free thiazole alcohol precursor. In the key step, 2‑chloromethyl‑4‑cyanothiazole is reacted with commercial 40% aqueous dimethylamine in tetrahydrofuran. The displacement is strongly exothermic; a 2000‑L Hastelloy C‑22 reactor equipped with a baffled cooling jacket and a pH‑probe‑interlocked dosing pump is employed to maintain internal temperature at 10–15°C and pH below 8.5. Above pH 9.2, base‑catalyzed ring‑opening of the thiazole cycle is observed, forming a mercaptoacrylonitrile side product that decomposes to foul‑smelling sulfur‑containing oligomers. The conductivity probe control software logs a dosing rate of ca. 2.5 L min−1 of dimethylamine solution, with jacket brine at −5°C to absorb the ca. 85 kJ mol−1 neutralisation enthalpy. After phase separation, the organic layer is washed with 25% NaCl solution and the residual water and excess dimethylamine are removed by azeotropic distillation with toluene at 40°C and 50 mbar. Stripped dimethylamine content must be <50 ppm (headspace GC, USP <467>) before hydrogenation to prevent catalyst poisoning. On a 500‑L glass‑lined reactor train dedicated to hydrogenation, the nitrile intermediate is dissolved in methanol and passed through a molecular sieve 3A bed to achieve water content <0.1% w/w (Karl Fischer, USP <921> Method Ia). Reduction with 5% palladium on carbon (0.5% w/w dry catalyst) proceeds at 3.0 bar hydrogen overpressure and 30±2°C for 6–8 h in a stainless‑steel autoclave fitted with a gas‑dispersion turbine. Hot filtration over a sintered metal candle removes the catalyst, and the filtrate is concentrated under reduced pressure. 4‑Thiazolemethanol, 2‑[(dimethylamino)methyl]‑ distills at 115–117°C at 0.3 mmHg (pale oil). Batch yields from the nitrile are consistently 88–91% with an assay of >99.0% area by HPLC when the work‑up pH is controlled; failure to strip residual dimethylamine before hydrogenation causes the pH to exceed 9.0 in the reactor and lowers selectivity by 12–15% due to enamine formation. Post‑distillation, the product is stabilised with 50 ppm BHT to inhibit air‑oxidation of the thiazole sulfur.

    Specification Matrix and Pharmacopoeial Alignment

    Industrial batches are released against a monograph that harmonises with ICH Q6A decision trees for new drug substance intermediates. The analytical suite relies entirely on compendial methods where applicable, with in‑house validations performed according to the ICH Q2(R1) guidelines. Key acceptance criteria and the corresponding test standards are summarised.
    AttributeAcceptance CriterionTest Method
    AppearancePale yellow, clear liquid; free of suspended matterVisual inspection; Ph.Eur. 2.2.1
    Assay (anhydrous, solvent‑free)98.0–102.0% as C7H12N2OSUSP <621> HPLC; C18, 0.1% TFA/H2O–MeCN gradient
    Isomeric purity (2‑ vs 5‑substituted thiazole)2‑substituted isomer ≥99.8% area1H‑NMR (400 MHz, CDCl3); δ 7.15 ppm singlet for 4‑H
    Water content≤0.50% w/wKarl Fischer coulometry; USP <921> Method Ic
    Residual dimethylamine≤50 ppmHeadspace GC‑FID; USP <467> Procedure A, amine‑specific column
    Residual palladium (from catalyst)≤5 ppmICP‑MS; Ph.Eur. 2.4.20
    Individual organic impurity (2‑chloromethyl‑4‑cyanothiazole)≤0.20%USP <621> HPLC, RRT 1.87 vs. main peak
    Total organic impurities≤2.0%USP <621> HPLC
    The residual solvent profile is governed by ICH Q3C. Dimethylamine is classified as a Class 3 solvent with a permitted daily exposure of 50 mg (Option 1 limit 5000 ppm in the final drug substance, but in intermediate specifications a target of <50 ppm is enforced to account for downstream accumulation). Toluene, often used in the azeotropic drying step, is controlled to ≤890 ppm (Class 2, Option 1). Methanol is monitored with an acceptance value below 3000 ppm.

    Distinctions from Thiazole‑4‑methanol and Other 2‑Substituted Analogs

    Removal of the dimethylaminomethyl arm yields thiazole‑4‑methanol (CAS 7038‑00‑0), a crystalline solid with m.p. 37–39°C that is freely soluble in water but lacks the tertiary amine functionality. The unsubstituted compound serves as a fragrance ingredient (FEMA 4448) and requires an additional Mannich‑type transformation when employed in drug synthesis, adding at least two synthetic steps. Its boiling point of 112–114°C at 10 mmHg is lower than that of the dimethylamino derivative, but the lack of a basic site precludes pH‑dependent liquid‑liquid extraction and complicates enantiomeric enrichment via diastereomeric salt formation. The 2‑(aminomethyl) analog, introduced in early synthetic routes, displays a primary amine that undergoes rapid Schiff‑base formation with aldehyde impurities and is prone to autocondensation at pH >7.0. Comparative thermal safety screenings by DSC (Mettler Toledo HP DSC827e, 20°C min−1 under nitrogen) show an exothermic onset at 169°C for the primary amine, while the tertiary amine hydrochloride decomposes only above 215°C, with a decomposition energy of −420 J g−1 versus −780 J g−1 for the former. This difference translates to a safer processing window on scale when extended heating is required for solvent swaps. 2‑Chloromethyl‑4‑thiazolemethanol, an alternative electrophilic intermediate, reacts directly with nucleophiles but introduces a genotoxic alkylating agent that must be purged to <1.5 µg day−1 according to the TTC concept (EMEA/CHMP/QWP/251344/2006). Monitoring residual alkyl chloride by LC‑MS/MS at the ppb level adds substantial analytical burden. In contrast, the dimethylamino derivative’s potential mutagenicity concern is negligible, and any trace dimethylamine is volatile and easily removed under vacuum, allowing facilities to operate with simplified containment strategies.
    Physicochemical comparison of 2‑substituted thiazole‑4‑methanol derivatives
    Property2‑[(Dimethylamino)methyl]‑4‑thiazolemethanolThiazole‑4‑methanol2‑(Aminomethyl)‑4‑thiazolemethanol
    CAS number137523-43-47038-00-0938459-19-5*
    Physical state at 25°CViscous oilWaxy solidLow‑melting solid
    Boiling point (reduced pressure)115–117°C at 0.3 mmHg112–114°C at 10 mmHgDecomposes before distillation
    Aqueous solubility 25°C (pH 2)>200 mg mL−1180 mg mL−1>200 mg mL−1
    pKa conjugate acid8.3N/A9.4
    Key applicationProtease inhibitor intermediateFlavour & fragrance builing blockEarly‑phase drug synthesis (abandoned)
    Major process riskHygroscopicity; dimethylamine carry‑overSublimation during dryingRunaway decomposition above 170°C

    *listed for reference only; commercial availability is limited.

    Under ICH Q7 Section 7, the point at which a compound is designated as a registered starting material for an active pharmaceutical ingredient determines the regulatory change‑control burden. In the nelfinavir filing, 4‑thiazolemethanol, 2‑[(dimethylamino)methyl]‑ is introduced five steps before the final API. Consequently, a DMF (Type II) supports the intermediate and specifies a retest date of 12 months when stored at 2–8°C under argon in amber‑glass containers. Stability‑indicating HPLC data generated at 25°C/60% RH over 36 months show ≤0.3% assay loss, with no new impurity exceeding the identification threshold of 0.10%. Any variation in the supplier’s route that alters the impurity profile above the reporting threshold (0.05%) triggers post‑approval change management described in the CMC PIL under 21 CFR 314.70. Dichloromethane and chloroform are explicitly excluded from the manufacturing process in the regulatory dossier, aligning with the ICH Q3C residual solvent policy and the Montreal Protocol’s phase‑out of ozone‑depleting substances. The substance is registered under REACH as a transported isolated intermediate manufactured and used under strictly controlled conditions, with a recommended maximum site‑limited volume of 2000 L per reactor to avoid thermal runaway scenarios predicted by adiabatic calorimetry (Phi‑Tec II 1.8‑L adiabatic vessel test).